Southern Oncology Clinical Research Unit

Bedford Park, South Australia 5042

4 studies enrolling now · 9 studies all time

What they study most

Adenoid Cystic Carcinoma, Advanced Solid Tumor, Advanced Solid Tumors, Advanced Solid Tumors Cancer, Bladder Cancer, Carcinoma in Situ, Cervical Cancer, Cervix Cancer, Claudin 6-positive Advanced/Metastatic Malignant Solid Tumors, Cutaneous Melanoma, Diffuse Large B Cell Lymphoma, Epithelial Ovarian Cancer

Studies at this site

• Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer — Recruiting now
• First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors — Recruiting now
• ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours — Recruiting now
• A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. — Recruiting now
• A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. — Recruiting now
• Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion — Running, not enrolling
• A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications — Stopped early
• A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors — Completed
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC — Running, not enrolling